Clinical research commercial drug supply 2024: We work closely with you to provide market insights needed in order to implement the best strategy to meet your commercial drug supply requirements. Our client testimonials attest to our unique, collaborative approach, which adds longstanding value and strong partnerships. Our aim is to understand your goals and to work to minimize waste, allowing you to reinvest those savings back into your R&D initiatives. We hold ourselves to the highest standards, delivering on time, and most importantly, with uncompromised quality and integrity. Read even more information on pharmaceutical risk mitigation and competitiveness.
True commitment to patient safety: ClientPharma is also committed to proactively driving quality — not only because it’s the foundation from which the pharmaceutical industry has been built, but we also understand the significance of the patients’ safety and well-being. It’s our professional duty to service our clients’ needs with the utmost attention and care. CP also has a personal stake in supporting the development of future medicines that will treat and help eliminate life threatening diseases, ensuring we enhance our lives and those of our loved ones.
Experts in accessing biosimilars and reference medicines that others cannot. We pride ourselves on the ability to access commercial medicines that others cannot, especially from challenging markets while always providing premier service and excellent, consultative guidance throughout your project. We overcome your comparator sourcing challenges. ClientPharma’s clinical trial project management team brings proficiency in overseeing and overcoming your commercial drug supply challenges.
Our temperature-controlled capabilities include 2°- 8°C and 15°- 25°C facilities, as well as access to specialist transport to manage deliveries around the world according to product temperature requirements. Extensive capabilities: Our capabilities include stock receipt, import & export expertise, in-territory regulatory specialists, product reconciliation and destruction services. You can trust us: Our highly trained logistics team is dedicated to providing a robust clinical trial supply chain and trusted product integrity with regulatory compliant distribution through validated temperature-controlled logistics. We provide the peace-of-mind you need, offering you with dedicated clinical trial supply chain solutions to meet the explicit needs of your clinical programs. Discover extra information on https://www.clientpharma.com/.
Meeting the needs of global clinical supply trials requires diversity in supply strategies to address the unique complexities of each country’s healthcare and medication distribution systems. The “one-size fits all” approach is not a single supply strategy; instead, it leverages the expertise of a supply vendor partnership that addresses the need for a multi-faceted supply chain strategy. Jeff Wiltrout, Ph.D., Senior Vice President of Business Development at TrialCard, stated, “The responsibilities of clinical trial supply and operations personnel are vast and intricate. They need partners that make complex tasks simple and efficient. The partnership between market leaders like TrialCard and ClientPharma simplifies our clients’ global commercial drug sourcing responsibilities by providing a variety of streamlined, agile and efficient processes.”
Supply and demand of pharmaceuticals are mutually exclusive. The supply chain is wholly reliant upon pharmaceutical companies being able to effectively forecast demand for a particular product. The process of forecasting is often made difficult when a new medicine has just been brought to market or rapid deployment of a drug needs to happen in response to a pandemic due to a lack of concrete evidence to base estimations on. In a survey of pharmaceutical Senior Managers it was reported that the majority of pharmaceutical companies had miscalculated demand for new medicines by up to 25%. Michael Lehmann, executive vice president of sales and marketing for Patheon, a global provider of outsourced pharmaceutical development and manufacturing said, “Making accurate demand forecasts is extremely challenging for pharmaceutical companies”.